Menu Search
Equities

Polarean Imaging PLC

PLLWF:PKC

Polarean Imaging PLC

Actions
  • Price (USD)0.052
  • Today's Change0.00 / 0.00%
  • Shares traded750.00k
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of May 24 2024 13:04 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Polarean Imaging PLC is a medical-imaging technology company, with an investigational drug-device combination product for magnetic resonance imaging (MRI). The Company and its subsidiary company operate as investigational drug-device combination companies operating in the high-resolution medical imaging research space. The Company develops equipment that enables existing MRI systems to achieve an improved level of pulmonary functional imaging and specializes in the use of hyperpolarized xenon gas (129Xe) as an imaging agent to visualize ventilation. 129Xe gas is being studied for visualization of gas exchange regionally in the smallest airways of the lungs, across the alveolar tissue membrane, and into the pulmonary bloodstream. The Company’s technology provides an investigational diagnostic approach, offering a non-invasive and radiation-free functional imaging platform. It operates in Canada, Germany, United Kingdom and United States. The Company’s subsidiary is Polarean, Inc.

  • Revenue in GBP (TTM)266.95k
  • Net income in GBP-11.22m
  • Incorporated2016
  • Employees28.00
  • Location
    Polarean Imaging PLC2500 Meridian Pkwy #175DURHAM 27713United StatesUSA
  • Phone+1 (919) 206-7900
  • Fax+1 (919) 206-7901
  • Websitehttps://polarean.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.